Implications of drug intoxication on donor utilization and outcomes in liver transplantation

Clin Transplant. 2024 Mar;38(3):e15276. doi: 10.1111/ctr.15276.

Abstract

Introduction: This study evaluates the implications of drug intoxication (DI) on donor utilization and outcomes in liver transplantation (LT).

Methods: The UNOS STAR database was evaluated for all potential donors and adult, first-time, whole LT between 2005 and 2019. Logistic regression analyses evaluated liver utilization; proportional hazards modeling assessed risk of 1-year graft loss.

Results: A total of 132 783 potential donors (10 205, 7.7% from DI), and 90 612 adult LT were identified (7490, 8.3% from DI). DI donors had median age 32 years (IQR 26-40 years, p < .001), were 42.6% female (n = 4346), and 15.5% were DCD donors (n = 1583). Utilization of DI donors changed over time, such that by 2015-2019 they were the most likely donor cause of death (COD) to be utilized. Among LT recipients, there were insignificant differences (<2% variance) in age, gender, ethnicity, and etiology of liver disease according to donor COD. Recipients with MELD scores >30 more frequently received grafts from donors with trauma (23.8%) and DI (21.8%) versus cardiovascular (20.0%) and CVA/stroke (19.9%, p < .001). Among DBD donors, DI-COD was associated with superior 1-year graft survival compared to donors from trauma (HR 1.172, 95% CI 1.057-1.300) and CVA/stroke (HR 1.404, 95% CI 1.264-1.561, p < .001). Donor COD was not significantly associated with 1-year graft loss among DCD donors.

Conclusions: There is an increased likelihood of donor utilization when COD is drug overdose and an increased likelihood of 1-year graft survival compared to donors from trauma, CVA/stroke, and other COD.

Keywords: donor utilization; drug intoxication; graft survival; opioids crisis.

MeSH terms

  • Adult
  • Cause of Death
  • Female
  • Graft Survival
  • Humans
  • Liver Transplantation*
  • Male
  • Retrospective Studies
  • Stroke*
  • Tissue Donors